Safety and efficacy of treatment of children and adolescents with elevated low density lipoprotein levels with a step two diet or with lovastatin

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 11, Issue 5 SUPPL. 5, 2001, Pages 30-34

  Kwiterovich Jr , P O ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Development; Drugs; Familial hypercholesterolemia; Growth; Low fat diet

Indexed keywords

HYPOCHOLESTEROLEMIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN;

ADOLESCENT; ARTERIOSCLEROSIS; BLOOD; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIET THERAPY; FAT INTAKE; FEMALE; FOLLOW UP; HUMAN; LOW FAT DIET; MALE; RANDOMIZED CONTROLLED TRIAL; REVIEW; SAFETY; TREATMENT OUTCOME;

ADOLESCENT; ANTICHOLESTEREMIC AGENTS; ARTERIOSCLEROSIS; CHILD; CHOLESTEROL, LDL; DIET, FAT-RESTRICTED; DIETARY FATS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LOVASTATIN; MALE; RANDOMIZED CONTROLLED TRIALS; SAFETY; TREATMENT OUTCOME;

EID: 17144447026     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. National Cholesterol Education Program (NCEP): highlights of the report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents (1992) Pediatrics 89: 495-501
2. National Cholesterol Education Program Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents (1992) Pediatrics 89: 525-584
3. Kwiterovich PO Jr (1994) Dyslipoproteinemia and other risk factors for atherosclerosis in children and adolescents. Atherosclerosis 108: S55-S71
4. rd, Tracy RE, Wattigney WA (1998) Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 338: 1650-1656
5. Freedman DS, Dietz WH, Srinivasan SR, Berenson GS (1999) The relation of overweight to cardiovascular risk factors among children and adolescents: the Bogalusa Heart Study. Pediatrics 103: 1175-1182
6. Chen W, Srinivasan SR, Elkasabany A, Berenson GS (1999) Cardiovascular risk factors clustering features of insulin resistance syndrome (Syndrome X) in a biracial (Black-White) population of children, adolescents, and young adults: The Bogalusa Heart Study. Am J Epidemiol 150: 667-674
7. Kwiterovich PO Jr (1989) Pediatric implications of heterozygous familial hypercholesterolemia. Screening and dietary treatment. Arteriosclerosis 9: 1111-1120
8. Hobbs HH, Brown MS, Goldstein JL (1992) Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Hum Mutat 1: 445-466
9. Cortner JA, Coates PM, Gallagher PR (1990) Prevalence and expression of familial combined hyperlipidemia in childhood. J Pediatr 116: 514-524
10. Kwiterovich PO Jr (2000) The metabolic pathways of high-density lipoprotein, low-density lipoprotein, and triglycerides: a current review. Am J Cardiol 86: 5L-10L
11. Ye SQ, Kwiterovich PO Jr (2000) Influence of genetic polymorphisms on the responsiveness to dietary fat and cholesterol. Am J Clin Nutr 72: 1275S-1284S
12. Klag MJ, Ford DE, Mead LA, He J, Whelton PK, Liang KY, Levine DM (1993) Serum cholesterol in young men and subsequent cardiovascular disease. N Engl J Med 328: 313-318
13. Efficacy and safety of lowering dietary intake of fat and cholesterol in children with elevated low-density lipoprotein cholesterol. The Dietary Intervention Study in Children (DISC). The Writing Group for the DISC Collaborative Research Group (1995) JAMA 273: 1429-1435
14. Obarzanek E, Kimm SY, Barton BA, Van Horn LL, Kwiterovich PO Jr, Simons-Morton DG, Hunsberger SA, Lasser NL, Robson AM, Franklin FA Jr, Lauer RM, Stevens VJ, Friedman LA, Dorgan JF, Greenlick MR (2001) Long-term safety and efficacy of a cholesterol-lowering diet in children with elevated low-density lipoprotein cholesterol: seven-year results of the Dietary Intervention Study in Children (DISC) Pediatrics 107: 256-264
15. Kwiterovich PO Jr (1998) State-of-the-art update and review: clinical trials of lipid-lowering agents. Am J Cardiol 82: 3U-17U
16. Stein EA, Illingworth DR, Kwiterovich PO Jr, Liacouras CA, Siimes MA, Jacobson MS, Brewster TG, Hopkins P, Davidson M, Graham K, Arensman F, Knopp RH, DuJovne C, Williams CL, Isaacsohn JL, Jacobsen CA, Laskarzewski PM, Ames S, Gormley GJ (1999) Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlled trial. JAMA 281: 137-144